|
| 34726124 | Elevated Fab glycosylation of anti-hinge antibodies. | Scandinavian Journal of Rheumatology | 2023 |
| 36250739 | Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple Sclerosis. | Annals of Neurology | 2023 |
| 35551063 | EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases. | Annals of the Rheumatic Diseases | 2023 |
| 38053460 | Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated. | | 2023 |
| 37859583 | Formation and clearance of TNF-TNF inhibitor complexes during TNF inhibitor treatment. | | 2023 |
| 36716916 | Drug-tolerant detection of anti-drug antibodies in an antigen-binding assay using europium chelate fluorescence. | | 2023 |
| 37398978 | Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands. | | 2023 |
| 36621174 | Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations. | | 2023 |
| 37055152 | Rheumatoid factor autoantibody repertoire profiling reveals distinct binding epitopes in health and autoimmunity. | | 2023 |
| 36987655 | EULAR study group on 'MHC-I-opathy': identifying disease-overarching mechanisms across disciplines and borders. | Ann Rheum Dis | 2023 |
| 36720583 | Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases. | | 2023 |
| 35234569 | Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial. | Scandinavian Journal of Rheumatology | 2023 |
| 35156061 | COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases. | Lancet Rheumatology, The | 2022 |
| 35523569 | Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod. | Neurology: Neuroimmunology and NeuroInflammation | 2022 |
| 35838348 | Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273. | eLife | 2022 |
| 36357161 | Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases. | Annals of the Rheumatic Diseases | 2022 |
| 36034738 | SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period. | Lancet Rheumatology, The | 2022 |
| 35383121 | Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study. | RMD Open | 2022 |
| 36333501 | Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis. | Nat Genet | 2022 |
| 35980738 | Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider. | RMD Open | 2022 |
| 36713570 | Case report: Pharmacokinetics of pembrolizumab in a patient with stage IV non-small cell lung cancer after a single 200 mg administration. | | 2022 |
| 34251329 | Anti-rituximab antibodies affect pharmacokinetics and pharmacodynamics of rituximab in children with immune-mediated diseases. | Clinical and Experimental Rheumatology | 2022 |
| 34796848 | Is there a potential for therapeutic drug monitoring of subcutaneously administered tocilizumab in patients with rheumatoid arthritis in daily practice? | Clinical and Experimental Rheumatology | 2022 |
| 34977601 | Rituximab during the COVID-19 pandemic: time to discuss treatment options with patients. | Lancet Rheumatology, The | 2022 |
| 34847379 | Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate? | Multiple Sclerosis and Related Disorders | 2022 |
| 34493490 | Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy. | Annals of the Rheumatic Diseases | 2022 |
| 34396154 | Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies. | Lancet Rheumatology, The | 2021 |
| 31744825 | Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka . | Annals of the Rheumatic Diseases | 2021 |
| 34179831 | Adverse events after first COVID-19 vaccination in patients with autoimmune diseases. | Lancet Rheumatology, The | 2021 |
| 34147123 | Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch): study protocol for a fully blinded randomised superiority test-treatment trial. | Trials | 2021 |
| 33655220 | Perspective of patients with autoimmune diseases on COVID-19 vaccination. | Lancet Rheumatology, The | 2021 |
| 33979301 | High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages. | Sci Transl Med | 2021 |
| 33926495 | Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA). | Pediatric Rheumatology | 2021 |
| 34348783 | Spinning straw into gold: description of a disruptive rheumatology research platform inspired by the COVID-19 pandemic. | | 2021 |
| 33361116 | Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity. | Science | 2021 |
| 33403697 | Comprehensive evaluation of microneedle-based intradermal adalimumab delivery vs. subcutaneous administration: results of a randomized controlled clinical trial. | British Journal of Clinical Pharmacology | 2021 |
| 34854595 | [Swelling at the sternoclavicular joint]. | Nederlands Tijdschrift voor Geneeskunde | 2021 |
| 31498069 | The effect of certolizumab drug concentration and anti-drug antibodies on TNF neutralisation. | Clinical and Experimental Rheumatology | 2020 |
| 31691828 | The effect of methotrexate on tumour necrosis factor concentrations in etanercept-treated rheumatoid arthritis patients. | Rheumatology | 2020 |
| 32174918 | Immunogenicity of TNF-Inhibitors. | Frontiers in Immunology | 2020 |
| 32289181 | Divergent chemokine receptor expression and the consequence for human IgG4 BÂ cell responses. | European Journal of Immunology | 2020 |
| 32990892 | Interchangeability of Biosimilars: What Level of Clinical Evidence is Needed to Support the Interchangeability Designation in the United States? | BioDrugs | 2020 |
| 32648642 | Identification of Clinically and Pathophysiologically Relevant Rheumatoid Factor Epitopes by Engineered IgG Targets. | Arthritis and Rheumatology | 2020 |
| 32514745 | Evaluation of dose-tapering strategies for intravenous tocilizumab in rheumatoid arthritis patients using model-based pharmacokinetic/pharmacodynamic simulations. | European Journal of Clinical Pharmacology | 2020 |
| 33127820 | Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19. | Journal of Immunology | 2020 |
| 33106791 | Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population. | Lancet Rheumatology, The | 2020 |
| 31072816 | Response to: 'Tapering without relapse in rheumatoid arthritis patients with high TNF blocker concentrations: data from the STRASS study' by Marotte . | Annals of the Rheumatic Diseases | 2020 |
| 30943139 | Antidrug antibody detection for adalimumab depends on the type of assay used: an experimental approach to help clinicians interpret diagnostic data. | Clinical and Experimental Rheumatology | 2019 |
| 30323005 | Differences in Palmoplantar Pustulosis and Psoriasis Vulgaris in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Treated with Biological Therapy. | Journal of Rheumatology | 2019 |
| 30767391 | Efficacious transition from reference infliximab to biosimilar infliximab in clinical practice. | International Journal of Rheumatic Diseases | 2019 |